Details for New Drug Application (NDA): 212138
✉ Email this page to a colleague
The generic ingredient in EMPAGLIFLOZIN is empagliflozin; metformin hydrochloride. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the empagliflozin; metformin hydrochloride profile page.
Summary for 212138
Tradename: | EMPAGLIFLOZIN |
Applicant: | Zydus Pharms |
Ingredient: | empagliflozin |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Aug 3, 2022 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Aug 3, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription